Cargando…

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Dlouhy, Ivan, Armengol, Marc, Recasens-Zorzo, Clara, Ribeiro, Marcelo L, Pérez-Galán, Patricia, Bosch, Francesc, López-Guillermo, Armando, Roué, Gaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Errata Corrige
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713549/ https://www.ncbi.nlm.nih.gov/pubmed/36453521 http://dx.doi.org/10.3324/haematol.2022.281988

Ejemplares similares

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation
por: Dlouhy, Ivan, et al.
Publicado: (2021)

ARID5B influences B-cell development and function in mouse
por: Goodings, Charnise, et al.
Publicado: (2023)

This corrects the article “Kikuchi-Fujimoto Disease in the Unites States: Three Case Reports and Review of the Literature” in volume 6, e2014001, link: http://www.mjhid.org/article/view/11988
Publicado: (2014)

“Eating and Nutrition Habits in Young Competitive Athletes: A Comparison Between Soccer Players and Cyclists”
por: Galanti, G., et al.
Publicado: (2014)

Errata corrige
Publicado: (2019)

Errata
Publicado: (2018)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Errata
Publicado: (2020)

Errata
Publicado: (2020)

Errata corrige
Publicado: (2019)

Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE)
por: Nikkilä, Atte, et al.
Publicado: (2020)

Low-dose ionizing radiations leave scars on human hematopoietic stem and progenitor cells: the role of reactive oxygen species
por: Yamashita, Masayuki, et al.
Publicado: (2021)

A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
por: Beksac, Meral, et al.
Publicado: (2021)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021)

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
por: Lazaryan, Aleksandr, et al.
Publicado: (2021)

Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes
por: Gaymes, Terry J, et al.
Publicado: (2021)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
por: Schjesvold, Fredrik, et al.
Publicado: (2022)

Errata
Publicado: (2022)

ERRATA CORRIGE
Publicado: (2021)

ERRATA CORRIGE
Publicado: (2022)

ERRATA CORRIGE
Publicado: (2022)

ERRATA CORRIGE
Publicado: (2023)

ERRATA CORRIGE
Publicado: (2023)

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
por: Kloos, Robin Q.H., et al.
Publicado: (2023)

ERRATA CORRIGE
Publicado: (2023)

Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance
por: Wang, James Q., et al.
Publicado: (2014)

MYD88(L265P) and MYD88(other) variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
por: Qin, Yan, et al.
Publicado: (2023)

Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
por: Ansell, S M, et al.
Publicado: (2014)

Schnitzler syndrome associated with MYD88 L265P mutation
por: Goodman, Aaron M., et al.
Publicado: (2019)

PB2403: THE FREQUENCY OF L265P MUTATION IN MYD88 GENE AT DIFFUSE LARGE B-CELL LYMPHOMA
por: Dubrovina, Anastasiya, et al.
Publicado: (2023)

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis
por: Lee, Ju-Han, et al.
Publicado: (2017)

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
por: Munshi, Manit, et al.
Publicado: (2020)

Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Synergistic cooperation and crosstalk between MYD88(L265P) and mutations that dysregulate CD79B and surface IgM
por: Wang, James Q., et al.
Publicado: (2017)

Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR
por: Niu, Jing, et al.
Publicado: (2020)

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain
por: Minderman, Marthe, et al.
Publicado: (2023)

Preneoplastic somatic mutations including MYD88(L265P) in lymphoplasmacytic lymphoma
por: Rodriguez, Sara, et al.
Publicado: (2022)

Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report
por: Huang, Wen-Ye, et al.
Publicado: (2022)

High frequency and prognostic value of MYD88 L265P mutation in diffuse large B-cell lymphoma with R-CHOP treatment
por: Yu, Sisi, et al.
Publicado: (2018)

High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies
por: Çınar, Özcan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjkgr5e2f6f6ep85haur636mt4